J Korean Med Assoc.  2013 Dec;56(12):1057-1066. 10.5124/jkma.2013.56.12.1057.

Antidote for organophosphate insecticide poisoning: atropine and pralidoxime

• Chung SP
• Roh HK

• KMID: 1783720
• DOI: http://doi.org/10.5124/jkma.2013.56.12.1057

Abstract

Acute organophosphate (OP) poisoning produces cholinergic symptoms resulting from the inhibition of cholinesterase, and the overstimulation of muscarinic and nicotinic receptors in the synapses. The dominant clinical features of acute cholinergic toxicity include bradycardia, miosis, lacrimation, salivation, bronchorrhea, and bronchospasm. All symptomatic patients should receive therapy with oxygen, atropine, and pralidoxime. Atropine works as a physiologic antidote by competitively occupying muscarinic receptor sites, reducing the effects of excessive acetylcholine. Atropine should be immediately administered, and the dose can be titrated according to the severity of OP poisoning. A large dose may be necessary to overcome the excessive cholinergic state in case of severe poisoning. Pralidoxime is a biochemical antidote that reactivates acetylcholinesterase by removing OP from it. It is effective in treating both muscarinic and nicotinic symptoms. After some period of time, the acetylcholinesterase-OP compound undergoes a conformational change, known as aging, which renders the enzyme irreversibly resistant to reactivation by a pralidoxime. There has been a great deal of controversy over the effectiveness of pralidoxime in acute OP poisoning. However, it may be beneficial to administer pralidoxime for a sufficient period in case of severe poisoning with a large quantity of OP, which is common in Korea.

Keyword

Organophosphate; Poisoning; Antidote; Atropine; Pralidoxime

MeSH Terms

Acetylcholine
Acetylcholinesterase
Aging
Atropine*
Bradycardia
Bronchial Spasm
Cholinesterases
Humans
Korea
Miosis
Oxygen
Poisoning*
Pralidoxime Compounds
Receptors, Muscarinic
Receptors, Nicotinic
Salivation
Synapses
Acetylcholine
Acetylcholinesterase
Atropine
Cholinesterases
Oxygen
Pralidoxime Compounds
Receptors, Muscarinic
Receptors, Nicotinic

Reference

1. Lee MJ, Kwon WY, Park JS, Eo EK, Oh BJ, Lee SW, Suh JH, Roh HK. Clinical characteristics of acute pure organophosphate compounds poisoning: 38 multi-centers survey in South Korea. J Korean Soc Clin Toxicol. 2007; 5:27–35.

2. Bird S, Traub SJ, Grayzel J. Organophosphate and carbamate poisoning [Internet]. Waltham: UpToDate;2013. cited 2013 Nov 12. Available from: http://www.uptodate.com/contents/organophosphate-and-carbamate-poisoning?source=search_result&search=Organophosphate+and+carbamate+poisoning&selectedTitle=1%7E14.

3. Harris LW, Talbot BG, Lennox WJ, Anderson DR. The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal efficacy against carbamate intoxication. Toxicol Appl Pharmacol. 1989; 98:128–133.

4. Merrill DG, Mihm FG. Prolonged toxicity of organophosphate poisoning. Crit Care Med. 1982; 10:550–551.

5. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med. 2000; 12:22–37.

6. Asari Y, Kamijyo Y, Soma K. Changes in the hemodynamic state of patients with acute lethal organophosphate poisoning. Vet Hum Toxicol. 2004; 46:5–9.

7. Sahin I, Onbasi K, Sahin H, Karakaya C, Ustun Y, Noyan T. The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol. 2002; 21:175–177.

8. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med. 1987; 316:761–763.

9. Sevim S, Aktekin M, Dogu O, Ozturk H, Ertas M. Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can J Neurol Sci. 2003; 30:75–78.

10. Peter JV, Jerobin J, Nair A, Bennett A, Samuel P, Chrispal A, Abraham OC, Mathews KP, Fleming JJ, Oommen A. Clinical profile and outcome of patients hospitalized with dimethyl and diethyl organophosphate poisoning. Clin Toxicol (Phila). 2010; 48:916–923.

11. Suh JH, Roh HK. A case of amitraz insecticide intoxication after ingestion of large amount. J Korean Soc Clin Toxicol. 2008; 6:52–56.

12. Oh M, Go Y. General anesthesia using atracurium for patient with acute organophosphate poisoning: a case report. Korean J Anesthesiol. 2006; 51:233–235.

13. Eddleston M, Roberts D, Buckley N. Management of severe organophosphorus pesticide poisoning. Crit Care. 2002; 6:259.

14. Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, Buckley NA. Early management after self-poisoning with an organophosphorus or carbamate pesticide: a treatment protocol for junior doctors. Crit Care. 2004; 8:R391–R397.

15. Karakus A, Celik MM, Karcioglu M, Tuzcu K, Erden ES, Zeren C. Cases of organophosphate poisoning treated with high-dose of atropine in intensive care unit and the novel treatment approaches. Toxicol Ind Health. 2012; 09. 25. [Epub]. DOI:10.1177/0748233712462478.

16. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med. 2003; 10:1303–1306.

17. Roberts DM, Aaron CK. Management of acute organophosphorus pesticide poisoning. BMJ. 2007; 334:629–634.

18. Ali-Melkkila T, Kanto J, Iisalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand. 1993; 37:633–642.

19. Connors NJ, Harnett ZH, Hoffman RS. Comparison of current recommended regimens of atropinization in organophosphate poisoning. J Med Toxicol. 2013; 07. 31. [Epub]. DOI: 10.1007/s13181-013-0324-9.

20. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med. 1971; 50:475–492.

21. Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med. 2003; 10:295–298.

22. Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol. 2012; 8:108–117.

23. Perera PM, Shahmy S, Gawarammana I, Dawson AH. Comparison of two commonly practiced atropinization regimens in acute organophosphorus and carbamate poisoning, doubling doses vs. ad hoc: a prospective observational study. Hum Exp Toxicol. 2008; 27:513–518.

24. LeBlanc FN, Benson BE, Gilg AD. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol. 1986; 24:69–76.

25. Borowitz SM. Prolonged organophosphate toxicity in a twenty-six-month-old child. J Pediatr. 1988; 112:302–304.

26. Park JH, Park YJ, Kim SP, Cho SH, Kim SJ, Cho NS. Analysis of atropine induced psychosis in substance abuse patients. J Korean Soc Emerg Med. 2006; 17:336–343.

27. Sidell FR, Groff WA. Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J Pharm Sci. 1971; 60:1224–1228.

28. Eyer P, Eddleston M, Thiermann H, Worek F, Buckley NA. Are we using the right dose?: a tale of mole and gram. Br J Clin Pharmacol. 2008; 66:451–452.

29. Rump S, Faff J, Borkowska G, Ilczuk I, Rabsztyn T. Central therapeutic effects of dihydroderivative of pralidoxime (pro-2-PAM) in organophosphate intoxication. Arch Int Pharmacodyn Ther. 1978; 232:321–332.

30. Worek F, Backer M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol. 1997; 16:466–472.

31. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev. 2003; 22:165–190.

32. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett. 1999; 107:233–239.

33. Davison AN. Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. I. Diethyl p-nitrophenyl phosphate (E 600, paraoxon). Biochem J. 1953; 54:583–590.

34. Lifshitz M, Rotenberg M, Sofer S, Tamiri T, Shahak E, Almog S. Carbamate poisoning and oxime treatment in children: a clinical and laboratory study. Pediatrics. 1994; 93:652–655.

35. Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier. Neurochem Res. 2003; 28:1401–1407.

36. Lotti M, Becker CE. Treatment of acute organophosphate poisoning: evidence of a direct effect on central nervous system by 2-PAM (pyridine-2-aldoxime methyl chloride). J Toxicol Clin Toxicol. 1982; 19:121–127.

37. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM. 2002; 95:275–283.

38. Medicis JJ, Stork CM, Howland MA, Hoffman RS, Goldfrank LR. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. J Toxicol Clin Toxicol. 1996; 34:289–295.

39. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet. 2006; 368:2136–2141.

40. Wiener SW, Hoffman RS. Nerve agents: a comprehensive review. J Intensive Care Med. 2004; 19:22–37.

41. Holstege CP, Baer AB. Insecticides. Curr Treat Options Neurol. 2004; 6:17–23.

42. Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev. 2011; (2):CD005085.

43. Eddleston M, Eyer P, Worek F, Juszczak E, Alder N, Mohamed F, Senarathna L, Hittarage A, Azher S, Jeganathan K, Jayamanne S, von Meyer L, Dawson AH, Sheriff MH, Buckley NA. Pralidoxime in acute organophosphorus insecticide poisoning: a randomised controlled trial. PLoS Med. 2009; 6:e1000104.

44. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet. 2005; 366:1452–1459.

45. Chang P, Ganendran A. Pressor action of pyridine-2-aldoxime in malathion poisoning. Clin Exp Pharmacol Physiol. 1978; 5:125–130.

46. Kozak RJ, Siegel S, Kuzma J. Rapid atropine synthesis for the treatment of massive nerve agent exposure. Ann Emerg Med. 2003; 41:685–688.